抗JCV抗体检测呈阴性2周后出现的那他珠单抗相关进行性多灶性白质脑病 - Suppr

Suppr

超能文献

Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay.

作者信息

Gagne Brosseau Marie-Sarah, Stobbe Gary, Wundes Annette

机构信息

From the University of Washington, Seattle.

出版信息

Neurology. 2016 Feb 2;86(5):484-6. doi: 10.1212/WNL.0000000000002330. Epub 2016 Jan 6.

DOI:10.1212/WNL.0000000000002330

PMID:26740679

Abstract

摘要

相似文献

Neurology. 2016 Feb 2;86(5):484-6. doi: 10.1212/WNL.0000000000002330. Epub 2016 Jan 6.

Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.在那他珠单抗相关的进行性多灶性白质脑病之前，对多发性硬化症患者进行的纵向JCV血清学研究。

Mult Scler. 2015 Oct;21(12):1600-3. doi: 10.1177/1352458514567728. Epub 2015 Feb 6.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies.多发性硬化症患者使用那他珠单抗相关进行性多灶性白质脑病的风险：四项临床研究数据的回顾性分析。

Lancet Neurol. 2017 Nov;16(11):925-933. doi: 10.1016/S1474-4422(17)30282-X. Epub 2017 Sep 29.

Multiple sclerosis: Progressive multifocal leukoencephalopathy risk stratification.多发性硬化症：进行性多灶性白质脑病风险分层

Nat Rev Neurol. 2017 Dec;13(12):710-712. doi: 10.1038/nrneurol.2017.161. Epub 2017 Nov 17.

Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay.2009年至2016年那他珠单抗治疗患者进行性多灶性白质脑病（PML）发病率的统计分析：采用Stratify JCV® DxSelect™抗体检测后的结果

J Neurovirol. 2016 Dec;22(6):880-881. doi: 10.1007/s13365-016-0482-z. Epub 2016 Oct 11.

The effect of plasma exchange on serum anti-JC virus antibodies.血浆置换对血清抗 JC 病毒抗体的影响。

Mult Scler. 2013 Jun;19(7):912-9. doi: 10.1177/1352458512467502. Epub 2012 Dec 11.

Fatal natalizumab-associated progressive multifocal leukoencephalopathy with initial low JCV antibody index in a multiple sclerosis patient.一名多发性硬化症患者发生致命的那他珠单抗相关进行性多灶性白质脑病，初始JCV抗体指数较低

Rev Neurol (Paris). 2024 Jun;180(6):565-567. doi: 10.1016/j.neurol.2023.11.011. Epub 2024 Feb 29.

Application of the CSF JCV antibody index to early natalizumab-associated progressive multifocal leukoencephalopathy.脑脊液JCV抗体指数在早期那他珠单抗相关进行性多灶性白质脑病中的应用。

J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1092-1094. doi: 10.1136/jnnp-2016-315298. Epub 2017 May 10.

High cumulative JC virus seroconversion rate during long-term use of natalizumab.长期使用那他珠单抗期间 JC 病毒血清转化率高。

Eur J Neurol. 2016 Jun;23(6):1079-85. doi: 10.1111/ene.12988. Epub 2016 Mar 27.

Considerations for characterizing the risk of PML in natalizumab-treated patients.关于描述那他珠单抗治疗患者中进行性多灶性白质脑病（PML）风险的考量因素。

Mult Scler Relat Disord. 2016 Sep;9:121. doi: 10.1016/j.msard.2016.07.008. Epub 2016 Jul 11.

引用本文的文献

Risk Assessment of Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis Patients during 1 Year of Ocrelizumab Treatment.奥瑞珠单抗治疗多发性硬化症患者 1 年内进行进行性多灶性白质脑病风险评估。

Viruses. 2021 Aug 25;13(9):1684. doi: 10.3390/v13091684.

JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients.JCPyV miR-J1-5p 在那他珠单抗治疗多发性硬化症患者尿液中的表达。

Viruses. 2021 Mar 12;13(3):468. doi: 10.3390/v13030468.

Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).JC 病毒激活与进行性多灶性白质脑病（PML）中宿主-免疫相互作用。

J Neuroimmune Pharmacol. 2019 Dec;14(4):649-660. doi: 10.1007/s11481-019-09877-8. Epub 2019 Aug 27.

JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.JC 病毒 DNA 检测与那他珠单抗治疗多发性硬化症患者外周血中 CD8 效应细胞积累相关，与 JC 病毒血清状态无关。

Biomed Res Int. 2018 Feb 27;2018:5297980. doi: 10.1155/2018/5297980. eCollection 2018.

Progressive multifocal leukoencephalopathy and hematologic malignancies: a single cancer center retrospective review.进行性多灶性白质脑病与血液系统恶性肿瘤：单癌症中心回顾性研究

Blood Adv. 2017 Oct 18;1(23):2041-2045. doi: 10.1182/bloodadvances.2017008201. eCollection 2017 Oct 24.

The role of natalizumab in the treatment of multiple sclerosis: benefits and risks.那他珠单抗在多发性硬化治疗中的作用：益处与风险。

Ther Adv Neurol Disord. 2017 Sep;10(9):327-336. doi: 10.1177/1756285617716002. Epub 2017 Jun 23.

JCPyV microRNA in plasma inversely correlates with JCPyV seropositivity among long-term natalizumab-treated relapsing-remitting multiple sclerosis patients.长期接受那他珠单抗治疗的复发缓解型多发性硬化症患者的血浆 JCPyV microRNA 与 JCPyV 血清阳性呈负相关。

J Neurovirol. 2017 Oct;23(5):734-741. doi: 10.1007/s13365-017-0560-x. Epub 2017 Aug 22.

Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy.年龄是导致那他珠单抗相关性进行性多灶性白质脑病发病提前的危险因素。

J Neurovirol. 2017 Oct;23(5):742-749. doi: 10.1007/s13365-017-0561-9. Epub 2017 Aug 8.

Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis.免疫衰老：衰老在多发性硬化症治疗引发的神经感染性并发症易感性中的作用。

Curr Neurol Neurosci Rep. 2017 Aug;17(8):61. doi: 10.1007/s11910-017-0771-9.

PLoS One. 2016 Dec 20;11(12):e0168376. doi: 10.1371/journal.pone.0168376. eCollection 2016.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验